Cite
MLA Citation
Stephen Macfarlane et al.. “P4‐356: Safety and Efficacy 31 Week Data of Anavex 2‐73 in a Phase 2A Study in Mild‐Moderate Alzheimer'S Disease Patients.” Alzheimer's & dementia, vol. 12, n.d., p. P1174. http://access.bl.uk/ark:/81055/vdc_100102543369.0x00000d